Pathologically elevated levels of particularly P-Tau, a hyperphosphorylated form of Tau, have previously been associated with neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases [43]. The gene discussed is MAPT; the disease is Parkinson disease.